OSR HEALTH, INC. Total Liabilities and Equity
OSR HEALTH, INC. (OSRH) had Total Liabilities and Equity of $166.62 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-14
- 2026-06-30: Liabilities and Equity $166.62M.
- 2026-03-31: Liabilities and Equity $172.19M.
- 2025-12-31: Liabilities and Equity $171.24M; Liabilities and Equity as first filed $171.24M.
- 2025-09-30: Liabilities and Equity $177.29M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $166.62M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $172.19M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $171.24M 10-Q · filed 2026-08-14 | $171.24M 10-K · filed 2026-03-31 |
| 2025-09-30 | $177.29M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $185.42M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $174.55M 10-Q · filed 2025-05-20 | |
| 2024-12-31 | $175.24M 10-K · filed 2026-03-31 | $2.30M 10-K · filed 2025-04-22 |
| 2024-09-30 | $20.93M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $20.63M 10-Q · filed 2024-08-19 | |
| 2024-03-31 | $37.27M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $36.63M 10-K · filed 2025-04-22 | |
| 2023-09-30 | $72.14M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $71.49M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $71.06M 10-Q · filed 2023-05-22 | |
| 2022-12-31 | $1.23M 10-K · filed 2024-04-17 | |
| 2021-12-31 | $705.09K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |